| P50 | author | Chuen Neng Lee | Q39393110 |
| | Siu Kwan Sze | Q41595023 |
| P2093 | author name string | Esther Sok Hwee Cheow | |
| | Dominique de Kleijn | |
| | Vitaly Sorokin | |
| | Woo Chin Cheng | |
| P2860 | cites work | Exosomes: vehicles for the transfer of toxic proteins associated with neurodegenerative diseases? | Q21129257 |
| | Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery | Q21147047 |
| | Gene ontology: tool for the unification of biology | Q23781406 |
| | Apolipoprotein D: an overview of its role in aging and age-related diseases | Q24292893 |
| | FunRich: An open access standalone functional enrichment and interaction network analysis tool | Q24570140 |
| | Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL | Q24669594 |
| | Regulation of immune responses by extracellular vesicles | Q27006748 |
| | Microparticles, vascular function, and atherothrombosis | Q27016063 |
| | Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells | Q27860960 |
| | Apolipoprotein D | Q28142696 |
| | Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury | Q28272621 |
| | The PRoteomics IDEntifications (PRIDE) database and associated tools: status in 2013 | Q28710185 |
| | Heart disease and stroke statistics--2014 update: a report from the American Heart Association | Q29547691 |
| | Membrane vesicles as conveyors of immune responses | Q29547765 |
| | Complement: a key system for immune surveillance and homeostasis | Q29615484 |
| | Loss-of-function mutations in APOC3, triglycerides, and coronary disease | Q30408720 |
| | Virulence and immunomodulatory roles of bacterial outer membrane vesicles | Q33704480 |
| | Targeting of mannan-binding lectin-associated serine protease-2 confers protection from myocardial and gastrointestinal ischemia/reperfusion injury. | Q34179243 |
| | Loss-of-function mutations in APOC3 and risk of ischemic vascular disease | Q34425444 |
| | The inflammatory response in myocardial infarction | Q34463456 |
| | Microparticles in hemostasis and thrombosis. | Q35131040 |
| | The inflammatory response in myocardial injury, repair, and remodelling. | Q35529656 |
| | Effect of genetic variations in platelet glycoproteins Ibalpha and VI on the risk for coronary heart disease events in postmenopausal women taking hormone therapy | Q35642801 |
| | Simultaneous Enrichment of Plasma Soluble and Extracellular Vesicular Glycoproteins Using Prolonged Ultracentrifugation-Electrostatic Repulsion-hydrophilic Interaction Chromatography (PUC-ERLIC) Approach | Q35692136 |
| | Colocalisation of intraplaque C reactive protein, complement, oxidised low density lipoprotein, and macrophages in stable and unstable angina and acute myocardial infarction | Q35769679 |
| | The role of complement activation in atherosclerosis | Q35838666 |
| | Hydrogen sulfide preconditioning or neutrophil depletion attenuates ischemia-reperfusion-induced mitochondrial dysfunction in rat small intestine | Q35939346 |
| | HDAC inhibitors in experimental liver and kidney fibrosis | Q36588493 |
| | Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis | Q36591939 |
| | Human ApoD, an apolipoprotein up-regulated in neurodegenerative diseases, extends lifespan and increases stress resistance in Drosophila | Q36641874 |
| | Platelets as immune cells: bridging inflammation and cardiovascular disease | Q36699744 |
| | Insights into the platelet releasate | Q36952289 |
| | Apolipoprotein D in lipid metabolism and its functional implication in atherosclerosis and aging | Q37444311 |
| | Extracellular vesicle markers in relation to obesity and metabolic complications in patients with manifest cardiovascular disease | Q37568849 |
| | Small dense low-density lipoprotein-cholesterol concentrations predict risk for coronary heart disease: the Atherosclerosis Risk In Communities (ARIC) study | Q37723285 |
| | Exosomes: immune properties and potential clinical implementations | Q37822692 |
| | The role of microvesicles in tissue repair. | Q37875634 |
| | Pivotal role of paracrine effects in stem cell therapies in regenerative medicine: can we translate stem cell-secreted paracrine factors and microvesicles into better therapeutic strategies? | Q37969874 |
| | Exosomes and microvesicles: extracellular vesicles for genetic information transfer and gene therapy. | Q38032823 |
| | Roles of exosomes and microvesicles in disease pathogenesis | Q38043783 |
| | Extracellular vesicles in physiological and pathological conditions | Q38069314 |
| | Neutrophil roles in left ventricular remodeling following myocardial infarction. | Q38111517 |
| | Microvesicles as cell-cell messengers in cardiovascular diseases | Q38179330 |
| | Reduced oxidative stress in STEMI patients treated by primary percutaneous coronary intervention and with antioxidant therapy: a systematic review | Q38188472 |
| | Emerging role of extracellular vesicles in inflammatory diseases. | Q38188861 |
| | Defective functionality of small, dense HDL3 subpopulations in ST segment elevation myocardial infarction: Relevance of enrichment in lysophosphatidylcholine, phosphatidic acid and serum amyloid A. | Q38868098 |
| | Detection, evaluation and minimization of nonenzymatic deamidation in proteomic sample preparation | Q38901019 |
| | Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. | Q40452110 |
| | Interaction of endothelial microparticles with monocytic cells in vitro induces tissue factor-dependent procoagulant activity | Q40732139 |
| | The complement system in myocardial ischaemia/reperfusion injury | Q40751609 |
| | C-Reactive Protein Adds to the Predictive Value of Total and HDL Cholesterol in Determining Risk of First Myocardial Infarction | Q40857092 |
| | Marked reduction of free radical generation and contractile dysfunction by antioxidant therapy begun at the time of reperfusion. Evidence that myocardial "stunning" is a manifestation of reperfusion injury | Q41271714 |
| | Pexelizumab and survival in cardiac surgery | Q41622583 |
| | Adhesion of Activated Platelets to Endothelial Cells: Evidence for a GPIIbIIIa-dependent Bridging Mechanism and Novel Roles for Endothelial Intercellular Adhesion Molecule 1 (ICAM-1), αvβ3 Integrin, and GPIbα | Q42971426 |
| | Inhibition of mannose-binding lectin reduces postischemic myocardial reperfusion injury | Q43740164 |
| | Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: the COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trial | Q43777913 |
| | Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events | Q43891430 |
| | Protective effects of a potent C5a receptor antagonist on experimental acute limb ischemia-reperfusion in rats | Q44734358 |
| | Activated polymorphonuclear neutrophils disseminate anti-inflammatory microparticles by ectocytosis | Q44948880 |
| | C5a decreases regional coronary blood flow and myocardial function in pigs: implications for a granulocyte mechanism | Q46289879 |
| | Comparison of label-free methods for quantifying human proteins by shotgun proteomics. | Q46568113 |
| | Reduction of myocardial infarct size by neutrophil depletion: effect of duration of occlusion | Q47204619 |
| | Evaluation of the Effect of Trypsin Digestion Buffers on Artificial Deamidation | Q57236340 |
| | ApoD, a glia-derived apolipoprotein, is required for peripheral nerve functional integrity and a timely response to injury | Q59386593 |
| | Canine myocardial reperfusion injury. Its reduction by the combined administration of superoxide dismutase and catalase. | Q64997881 |
| | Elevation of C-reactive protein in "active" coronary artery disease | Q68696120 |
| | Fibrinogen as a risk factor for stroke and myocardial infarction | Q71438059 |
| | Monocyte vesiculation is a possible mechanism for dissemination of membrane-associated procoagulant activities and adhesion molecules after stimulation by lipopolysaccharide | Q71647217 |
| | Complement C5a, TGF-beta 1, and MCP-1, in sequence, induce migration of monocytes into ischemic canine myocardium within the first one to five hours after reperfusion | Q73047639 |
| | Mast cell-derived exosomes induce phenotypic and functional maturation of dendritic cells and elicit specific immune responses in vivo | Q73100796 |
| | Skeletal muscle reperfusion injury is mediated by neutrophils and the complement membrane attack complex | Q73278739 |
| | Novel role of platelets in mediating inflammatory responses and ventricular rupture or remodeling following myocardial infarction | Q83253167 |
| | Human mesenchymal stem cell-conditioned medium improves cardiac function following myocardial infarction | Q83653952 |
| | Preventive effects of zingerone on altered lipid peroxides and nonenzymatic antioxidants in the circulation of isoproterenol-induced myocardial infarcted rats | Q85656163 |
| | TFPI inhibits lectin pathway of complement activation by direct interaction with MASP-2 | Q85893127 |
| | Expression of anaphylatoxin receptors on platelets in patients with coronary heart disease | Q86415018 |
| | Circulating extracellular vesicles in cancer diagnosis and monitoring: an appraisal of clinical potential | Q86886262 |
| | Aging and dyslipidemia: a review of potential mechanisms | Q95615596 |
| P433 | issue | 8 | |
| P921 | main subject | biomarker | Q864574 |
| | extracellular vesicle | Q21097485 |
| P304 | page(s) | 2628-2640 | |
| P577 | publication date | 2016-05-27 | |
| P1433 | published in | Molecular & Cellular Proteomics | Q6895932 |
| P1476 | title | Plasma-derived Extracellular Vesicles Contain Predictive Biomarkers and Potential Therapeutic Targets for Myocardial Ischemic (MI) Injury | |
| P478 | volume | 15 | |